← USPTO Patent Grants

CD4+ T cells expressing IL-10 and chimeric antigen receptors and uses thereof

Grant US12576150B2 Kind: B2 Mar 17, 2026

Assignee

Tr1x, Inc.

Inventors

Jan Egbert De Vries, Maria Grazia Roncarolo, Xavier Paliard, David De Vries

Abstract

The present disclosure provides a population of CD4IL-10/CAR cells (autologous or allogeneic single-donor and allogeneic polydonor) generated by genetically modifying CD4+ T cells to express IL-10 and a chimeric antigen receptor. Further provided are methods of generating the CD4IL-10/CAR cells and methods of using the CD4IL-10/CAR cells for immune tolerization, treating GvHD, cell and organ transplantation, cancer, and other autoimmune and inflammatory disorders.

CPC Classifications

A61K 38/2066 A61K 40/31 C07K 14/5428 C07K 14/7051

Filing Date

2025-02-26

Application No.

19064325

Claims

5